AbbVie
ABBV
#26
Rank
โ‚น35.895 T
Marketcap
โ‚น20,310
Share price
-1.15%
Change (1 day)
39.89%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚น12.028 Trillion

According to AbbVie's latest financial reports the company's total assets are โ‚น12.028 Trillion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

AbbVie - Total assets on balance sheet (from 2011 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚น11.595 T3.39%
2023-12-31โ‚น11.214 T-2.36%
2022-12-31โ‚น11.486 T5.32%
2021-12-31โ‚น10.906 T-0.95%
2020-12-31โ‚น11.011 T73.28%
2019-12-31โ‚น6.354 T53.13%
2018-12-31โ‚น4.150 T-8.18%
2017-12-31โ‚น4.519 T0.62%
2016-12-31โ‚น4.491 T27.41%
2015-12-31โ‚น3.525 T102.18%
2014-12-31โ‚น1.743 T-3.33%
2013-12-31โ‚น1.803 T21.98%
2012-12-31โ‚น1.478 T43.2%
2011-12-31โ‚น1.032 T9.04%
2010-12-31โ‚น947.04 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
โ‚น18.751 T 55.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น8.704 T-27.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น10.325 T-14.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น8.097 T-32.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น5.258 T-56.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น2.623 T-78.19%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น7.407 T-38.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
โ‚น10.282 T-14.52%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น383.21 B-96.81%๐Ÿ‡บ๐Ÿ‡ธ USA